Beggs Clive B, Giaquinta Alessia, Veroux Massimiliano, De Marco Ester, Mociskyte Dovile, Veroux Pierfrancesco
Institute for Sport, Physical Activity and Leisure, School of Sport, Leeds Beckett University, Leeds, United Kingdom.
Vascular Surgery and Organ Transplant Unit, Azienda Ospedaliero-Universitaria Policlinico, Catania, Italy.
PLoS One. 2018 Jan 23;13(1):e0191534. doi: 10.1371/journal.pone.0191534. eCollection 2018.
Multiple sclerosis (MS) patients frequently suffer from headaches and fatigue, and many reports have linked headaches with intracranial and/or extracranial venous obstruction. We therefore designed a study involving MS patients diagnosed with obstructive disease of internal jugular veins (IJVs), with the aim of evaluating the impact of percutaneous transluminal angioplasty (PTA) on headache and fatigue indicators.
286 MS patients (175 relapsing remitting (RR), 75 secondary progressive (SP), and 36 primary progressive (PP)), diagnosed with obstructive disease of IJVs, underwent PTA of IJVs during the period 2011-2015. This included 113 headache positive patients (82 RR, 22 SP, and 9 PP) and 277 fatigue positive patients (167 RR, 74 SP, and 36 PP). Migraine Disability Assessment (MIDAS), and the Fatigue Severity Scale (FSS) were evaluated: before PTA; 3-months after PTA; and at final follow-up in 2017. Patients were evaluated with Doppler sonography of the IJVs at 1, 6 and 12 months after PTA and yearly thereafter. Non-parametric statistical analysis was performed using a combination of the Friedman test and Spearman correlation analysis.
With the exception of the PP patients there were significant reductions (all p < 0.001) in the MIDAS and FSS scores in the 3-month following PTA. The improvement in MIDAS score following PTA was maintained throughout the follow-up period in both the RR (p < 0.001; mean of 3.55 years) and SP (p = 0.002; mean of 3.52 years) MS cohorts. With FSS, significant improvement was only observed at 2017 follow-up in the RR patients (p < 0.001; mean of 3.37 years). In the headache-positive patients, post-PTA MIDAS score was significantly negatively correlated with the change in the blood flow score in the left (r = -0.238, p = 0.031) and right (r = -0.250, p = 0.023) IJVs in the RR patients and left IJV (r = -0.727, p = 0.026) in the PP patients. In the fatigue-positive cohort, post-PTA FSS score was also significantly negatively correlated with the change in blood flow in the right IJV in the PP patients (r = -0.423, p = 0.010). In addition, the pre and post-PTA FSS scores were significantly positively correlated in the fatigue-positive RR (r = 0.249, p = 0.001) and SP patients (r = 0.272, p = 0.019).
The intervention of PTA was associated with a large and sustained (>3 years) reduction in MIDAS score in both RR and SP MS patients. While a similar initial post-PTA reduction in FSS score was also observed, this was not maintained in the SP and PP patients, although it remained significant at follow-up (>3 years) in the RR MS patients. This suggests that venoplasty might be a useful intervention for treating patients with persistent headaches and selected concomitant obstructive disease of the IJVs.
多发性硬化症(MS)患者经常遭受头痛和疲劳之苦,许多报告将头痛与颅内和/或颅外静脉阻塞联系起来。因此,我们设计了一项针对被诊断患有颈内静脉(IJVs)阻塞性疾病的MS患者的研究,旨在评估经皮腔内血管成形术(PTA)对头痛和疲劳指标的影响。
286例被诊断患有IJVs阻塞性疾病的MS患者(175例复发缓解型(RR)、75例继发进展型(SP)和36例原发进展型(PP))在2011年至2015年期间接受了IJVs的PTA治疗。其中包括113例头痛阳性患者(82例RR、22例SP和9例PP)和277例疲劳阳性患者(167例RR、74例SP和36例PP)。在PTA前、PTA后3个月以及2017年最终随访时评估偏头痛残疾评估(MIDAS)和疲劳严重程度量表(FSS)。在PTA后1、6和12个月以及此后每年对患者进行IJVs的多普勒超声检查。使用Friedman检验和Spearman相关分析相结合的方法进行非参数统计分析。
除PP患者外,PTA后3个月时MIDAS和FSS评分均有显著降低(所有p<0.001)。PTA后MIDAS评分的改善在RR(p<0.001;平均3.55年)和SP(p=0.002;平均3.52年)MS队列的整个随访期内均得以维持。对于FSS,仅在2017年随访时RR患者中有显著改善(p<0.001;平均3.37年)。在头痛阳性患者中,PTA后RR患者左(r=-0.238,p=0.031)、右(r=-0.250,p=0.023)IJVs血流评分变化与MIDAS评分显著负相关,PP患者左IJV(r=-0.727,p=0.026)血流评分变化与MIDAS评分显著负相关。在疲劳阳性队列中,PP患者PTA后FSS评分也与右IJV血流变化显著负相关(r=-0.423,p=0.010)。此外,疲劳阳性RR(r=0.249,p=0.001)和SP患者(r=0.272,p=0.019)PTA前后FSS评分显著正相关。
PTA干预与RR和SP MS患者MIDAS评分大幅且持续(>3年)降低相关。虽然PTA后FSS评分最初也有类似降低,但在SP和PP患者中未得以维持,尽管在RR MS患者随访(>3年)时仍显著。这表明血管成形术可能是治疗持续性头痛及伴有IJVs阻塞性疾病患者的一种有效干预措施。